Medical and endoscopic therapy of primary sclerosing cholangitis

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 6, 2011, Pages 741-752

  Weismüller, Tobias J ^a   Lankisch, Tim O ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biliary tract; Drug therapy; Endoscopy; Primary sclerosing cholangitis; UDCA

Indexed keywords

24 NORURSODEOXYCHOLIC ACID; BEZAFIBRATE; EVEROLIMUS; FIBRIC ACID DERIVATIVE; METRONIDAZOLE; MINOCYCLINE; PLACEBO; RAPAMYCIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BALLOON DILATATION; ENDOSCOPIC THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIMARY SCLEROSING CHOLANGITIS; STENT;

ANTI-BACTERIAL AGENTS; BALLOON DILATION; CHOLAGOGUES AND CHOLERETICS; CHOLANGITIS, SCLEROSING; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; STENTS; URSODEOXYCHOLIC ACID;

EID: 82255165444     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.10.003     Document Type: Article

References (80)

1. A. Bergquist, A. Ekbom, R. Olsson, D. Kornfeldt, L. Loof, and A. Danielsson Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 2002 321 327 (Pubitemid 34194790)
2. M.M. Claessen, F.P. Vleggaar, K.M. Tytgat, P.D. Siersema, and H.R. van Buuren High lifetime risk of cancer in primary sclerosing cholangitis J Hepatol 50 2009 158 164
3. B. Lindkvist, M. Benito de Valle, B. Gullberg, and E. Bjornsson Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden Hepatology 52 2010 571 577
4. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, and B. Shneider Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2010 660 678
5. EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 2009 237 267
6. E. Bjornsson, R. Olsson, A. Bergquist, S. Lindgren, B. Braden, and R.W. Chapman The natural history of small-duct primary sclerosing cholangitis Gastroenterology 134 2008 975 980 (Pubitemid 351451987)
7. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938 (Pubitemid 29514229)
8. K.M. Boberg, R.W. Chapman, G.M. Hirschfield, A.W. Lohse, M.P. Manns, and E. Schrumpf Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue J Hepatol 54 2011 374 385
9. F.D. Mendes, R. Jorgensen, J. Keach, J.A. Katzmann, T. Smyrk, and J. Donlinger Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis Am J Gastroenterol 101 2006 2070 2075 (Pubitemid 44337633)
10. I. Nishimori, and M. Otsuki Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis Best Pract Res Clin Gastroenterol 23 2009 11 23
11. T.J. Weismuller, J. Wedemeyer, S. Kubicka, C.P. Strassburg, and M.P. Manns The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy J Hepatol 48 Suppl. 1 2008 S38 S57
12. T.H. Karlsen, A. Franke, E. Melum, A. Kaser, J.R. Hov, and T. Balschun Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 2010 1102 1111
13. E. Melum, A. Franke, C. Schramm, T.J. Weismuller, D.N. Gotthardt, and F.A. Offner Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci Nat Genet 43 2011 17 19
14. J.R. Hov, V. Keitel, J.K. Laerdahl, L. Spomer, E. Ellinghaus, and A. ElSharawy Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis PLoS One 5 2010 e12403
15. T.H. Karlsen, E. Schrumpf, and K.M. Boberg Update on primary sclerosing cholangitis Dig Liver Dis 42 2010 390 400
16. A.J. Grant, P.F. Lalor, M. Salmi, S. Jalkanen, and D.H. Adams Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease Lancet 359 2002 150 157 (Pubitemid 34112549)
17. M.J. Pollheimer, M. Trauner, and P. Fickert Will we ever model PSC? - "It's hard to be a PSC model!" Clin Res Hepatol Gastroenterol 2011
18. W.R. Kim, T.M. Therneau, R.H. Wiesner, J.J. Poterucha, J.T. Benson, and M. Malinchoc A revised natural history model for primary sclerosing cholangitis Mayo Clin Proc 75 2000 688 694 (Pubitemid 30441497)
19. E.L. Culver, and R.W. Chapman Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis Aliment Pharmacol Ther 33 2011 1273 1291
20. U. Beuers Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis Nat Clin Pract Gastroenterol Hepatol 3 2006 318 328 (Pubitemid 43842248)
21. O. Chazouilleres, R. Poupon, J.P. Capron, E.H. Metman, D. Dhumeaux, and M. Amouretti Ursodeoxycholic acid for primary sclerosing cholangitis J Hepatol 11 1990 120 123 (Pubitemid 20250837)
22. U. Beuers, U. Spengler, W. Kruis, U. Aydemir, B. Wiebecke, and W. Heldwein Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial Hepatology 16 1992 707 714
23. K.D. Lindor Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group N Engl J Med 336 1997 691 695
24. R. Olsson, K.M. Boberg, O.S. de Muckadell, S. Lindgren, R. Hultcrantz, and G. Folvik High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study Gastroenterology 129 2005 1464 1472 (Pubitemid 41597389)
25. D.M. Harnois, P. Angulo, R.A. Jorgensen, N.F. Larusso, and K.D. Lindor High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis Am J Gastroenterol 96 2001 1558 1562 (Pubitemid 32455090)
26. S.N. Cullen, C. Rust, K. Fleming, C. Edwards, U. Beuers, and R.W. Chapman High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective J Hepatol 48 2008 792 800
27. K.D. Lindor, K.V. Kowdley, V.A. Luketic, M.E. Harrison, T. McCashland, and A.S. Befeler High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis Hepatology 50 2009 808 814
28. E. Sinakos, H.U. Marschall, K.V. Kowdley, A. Befeler, J. Keach, and K. Lindor Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression Hepatology 52 2010 197 203
29. B.Y. Tung, M.J. Emond, R.C. Haggitt, M.P. Bronner, M.B. Kimmey, and K.V. Kowdley Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis Ann Intern Med 134 2001 89 95 (Pubitemid 32096335)
30. D.S. Pardi, E.V. Loftus Jr., W.K. Kremers, J. Keach, and K.D. Lindor Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis Gastroenterology 124 2003 889 893 (Pubitemid 36389790)
31. Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol.
32. G. Rudolph, P. Kloeters-Plachky, D. Rost, and A. Stiehl The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid Eur J Gastroenterol Hepatol 19 2007 487 491 (Pubitemid 46725755)
33. B. Brandsaeter, H. Isoniemi, U. Broome, M. Olausson, L. Backman, and B. Hansen Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy J Hepatol 40 2004 815 822 (Pubitemid 38507363)
34. A.F. Hofmann, S.F. Zakko, M. Lira, C. Clerici, L.R. Hagey, and K.K. Lambert Novel biotransformation and physiological properties of norursodeoxycholic acid in humans Hepatology 42 2005 1391 1398 (Pubitemid 43260042)
35. P. Fickert, M. Wagner, H.U. Marschall, A. Fuchsbichler, G. Zollner, and O. Tsybrovskyy 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 130 2006 465 481 (Pubitemid 43202044)
36. P. Angulo, K.P. Batts, R.A. Jorgensen, N.A. LaRusso, and K.D. Lindor Oral budesonide in the treatment of primary sclerosing cholangitis Am J Gastroenterol 95 2000 2333 2337
37. A. Floreani, E.R. Rizzotto, F. Ferrara, I. Carderi, D. Caroli, and L. Blasone Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome Am J Gastroenterol 100 2005 1516 1522 (Pubitemid 41032356)
38. K.M. Boberg, T. Egeland, and E. Schrumpf Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients Scand J Gastroenterol 38 2003 991 995 (Pubitemid 37158028)
39. G.V. Gregorio, B. Portmann, J. Karani, P. Harrison, P.T. Donaldson, and D. Vergani Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study Hepatology 33 2001 544 553 (Pubitemid 32185215)
40. G.J. Webster, S.P. Pereira, and R.W. Chapman Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis-overlapping or separate diseases? J Hepatol 51 2009 398 402
41. A. Ghazale, S.T. Chari, L. Zhang, T.C. Smyrk, N. Takahashi, and M.J. Levy Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy Gastroenterology 134 2008 706 715 (Pubitemid 351312724)
42. S.K. Asrani, M.D. Leise, C.P. West, M.H. Murad, R.A. Pedersen, and P.J. Erwin Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis Hepatology 52 2010 1360 1370
43. E. Patsenker, V. Schneider, M. Ledermann, H. Saegesser, C. Dorn, and C. Hellerbrand Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis J Hepatol 2011
44. Y. Pignochino, I. Sarotto, C. Peraldo-Neia, J.Y. Penachioni, G. Cavalloni, and G. Migliardi Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas BMC Cancer 10 2010 631
45. B. Herberger, H. Puhalla, M. Lehnert, F. Wrba, S. Novak, and A. Brandstetter Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma Clin Cancer Res 13 2007 4795 4799 (Pubitemid 47294786)
46. S.N. Lichtman, R.B. Sartor, J. Keku, and J.H. Schwab Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth Gastroenterology 98 1990 414 423 (Pubitemid 20037925)
47. R. Olsson, E. Bjornsson, L. Backman, S. Friman, K. Hockerstedt, and B. Kaijser Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers J Hepatol 28 1998 426 432 (Pubitemid 28133546)
48. A.A. Negm, A. Schott, R.P. Vonberg, T.J. Weismueller, A.S. Schneider, and S. Kubicka Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis Gastrointest Endosc 72 2010 284 291
49. E.S. Bjornsson, A.F. Kilander, and R.G. Olsson Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis-a study of bile cultures from ERCP Hepatogastroenterology 47 2000 1504 1508
50. M. Farkkila, A.L. Karvonen, H. Nurmi, H. Nuutinen, M. Taavitsainen, and P. Pikkarainen Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial Hepatology 40 2004 1379 1386 (Pubitemid 39657012)
51. M.G. Silveira, N.J. Torok, A.A. Gossard, J.C. Keach, R.A. Jorgensen, and J.L. Petz Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study Am J Gastroenterol 104 2009 83 88
52. Y.K. Davies, K.M. Cox, B.A. Abdullah, A. Safta, A.B. Terry, and K.L. Cox Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic J Pediatr Gastroenterol Nutr 47 2008 61 67
53. M. Ueki, M. Koda, S. Yamamoto, Y. Matsunaga, and Y. Murawaki Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats J Gastroenterol 41 2006 996 1004 (Pubitemid 44741413)
54. I. Strack, S. Schulte, H. Varnholt, S. Schievenbusch, U. Tox, and K. Wendland beta-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis Lab Invest 91 2011 252 261
55. U. Beuers, G.A. Kullak-Ublick, T. Pusl, E.R. Rauws, and C. Rust Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators? Clin Rev Allergy Immunol 36 2009 52 61
56. S. Mizuno, K. Hirano, M. Tada, K. Yamamoto, Y. Yashima, and H. Yagioka Bezafibrate for the treatment of primary sclerosing cholangitis J Gastroenterol 45 2010 758 762
57. P. Angulo, A.E. Bharucha, R.A. Jorgensen, C.K. DeSotel, W.J. Sandborn, and N.F. Larusso Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study Dig Dis Sci 44 1999 602 607 (Pubitemid 29137974)
58. A.E. Bharucha, R. Jorgensen, S.N. Lichtman, N.F. LaRusso, and K.D. Lindor A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis Am J Gastroenterol 95 2000 2338 2342
59. F.P. Vleggaar, J.F. Monkelbaan, and K.J. van Erpecum Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study Eur J Gastroenterol Hepatol 20 2008 688 692
60. P. Angulo, R.A. Jorgensen, K.V. Kowdley, and K.D. Lindor Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study Dig Dis Sci 53 2008 1716 1720 (Pubitemid 351624429)
61. A. Stiehl Primary sclerosing cholangitis: the role of endoscopic therapy Semin Liver Dis 26 2006 62 68 (Pubitemid 43320728)
62. M. Aljiffry, P.D. Renfrew, M.J. Walsh, M. Laryea, and M. Molinari Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis HPB (Oxford) 13 2011 79 90
63. D.N. Gotthardt, G. Rudolph, P. Kloters-Plachky, H. Kulaksiz, and A. Stiehl Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment Gastrointest Endosc 71 2010 527 534
64. J.J. Tischendorf, H. Hecker, M. Kruger, M.P. Manns, and P.N. Meier Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study Am J Gastroenterol 102 2007 107 114 (Pubitemid 46072050)
65. E. Bjornsson, J. Lindqvist-Ottosson, M. Asztely, and R. Olsson Dominant strictures in patients with primary sclerosing cholangitis Am J Gastroenterol 99 2004 502 508 (Pubitemid 38524130)
66. J.J. Tischendorf, P.N. Meier, A. Schneider, M.P. Manns, and M. Kruger Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis Scand J Gastroenterol 42 2007 1011 1017 (Pubitemid 47037125)
67. J.J. Tischendorf, M. Kruger, C. Trautwein, N. Duckstein, A. Schneider, and M.P. Manns Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis Endoscopy 38 2006 665 669 (Pubitemid 44044391)
68. T.O. Lankisch, J. Metzger, A.A. Negm, K. Vosskuhl, E. Schiffer, and J. Siwy Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis Hepatology 53 2011 875 884
69. S.J. van den Hazel, E.H. Wolfhagen, H.R. van Buuren, P.C. van de Meeberg, and D.J. Van Leeuwen Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group Endoscopy 32 2000 779 782
70. S.Y. Bangarulingam, A.A. Gossard, B.T. Petersen, B.J. Ott, and K.D. Lindor Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis Am J Gastroenterol 104 2009 855 860
71. J. Pohl, A. Ring, W. Stremmel, and A. Stiehl The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis Eur J Gastroenterol Hepatol 18 2006 69 74 (Pubitemid 43004884)
72. A.R. Baluyut, S. Sherman, G.A. Lehman, H. Hoen, and N. Chalasani Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis Gastrointest Endosc 53 2001 308 312 (Pubitemid 32207314)
73. M. Gluck, N.R. Cantone, J.J. Brandabur, D.J. Patterson, J.E. Bredfeldt, and R.A. Kozarek A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis J Clin Gastroenterol 42 2008 1032 1039
74. M. Kaya, B.T. Petersen, P. Angulo, T.H. Baron, J.C. Andrews, and C.J. Gostout Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis Am J Gastroenterol 96 2001 1059 1066 (Pubitemid 32319137)
75. C.Y. Ponsioen, K. Lam, A.W. van Milligen de Wit, K. Huibregtse, and G.N. Tytgat Four years experience with short term stenting in primary sclerosing cholangitis Am J Gastroenterol 94 1999 2403 2407 (Pubitemid 29420664)
76. N.S. Awadallah, Y.K. Chen, C. Piraka, M.R. Antillon, and R.J. Shah Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am J Gastroenterol 101 2006 284 291 (Pubitemid 43381669)
77. T. Itoi, and H.P. Wang Endoscopic management of bile duct stones Dig Endosc 22 Suppl. 1 2010 S69 S75
78. S. Wagner, M. Gebel, P. Meier, C. Trautwein, J. Bleck, and B. Nashan Endoscopic management of biliary tract strictures in primary sclerosing cholangitis Endoscopy 28 1996 546 551 (Pubitemid 26385589)
79. M.D. Skolkin, J.P. Alspaugh, W.J. Casarella, V.P. Chuang, and J.T. Galambos Sclerosing cholangitis: palliation with percutaneous cholangioplasty Radiology 170 1989 199 206 (Pubitemid 19016876)
80. J.J. Koornstra, L. Fry, and K. Monkemuller ERCP with the balloon-assisted enteroscopy technique: a systematic review Dig Dis 26 2008 324 329